Fund Holdings — Caligan Partners LP

Total Portfolio Value
$2.07B
Total Bought
$494.14M
Total Sold
$203.41M
Net Transaction
+$290.72M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
LIQUIDIA CORPORATION(LQDA)8,118,8928,118,8920306,407647,31931.23%+340,912
REVOLUTION MEDICINES INC(RVMD)1,652,8081,961,795+308,987160,736367,40517.73%+206,669
ABIVAX SA(ABVX)1,461,9241,557,924+96,000162,785207,60910.02%+44,824
IMMUNOCORE HLDGS PLC(IMCR)01,381,317+1,381,317043,8572.12%+43,857
VIRIDIAN THERAPEUTICS INC(VRDN)02,193,981+2,193,981040,3031.94%+40,303
AVALO THERAPEUTICS INC(AVTX)1,635,0233,163,866+1,528,84324,41158,4682.82%+34,057
AURA BIOSCIENCES INC(AURA)229,8644,298,248+4,068,3841,53830,5181.47%+28,980
TANGO THERAPEUTICS INC(TNGX)2,408,7982,500,103+91,30550,39278,1533.77%+27,761
SAGIMET BIOSCIENCES INC(SGMT)02,500,000+2,500,000019,3250.93%+19,325
EXELIXIS INC(EXEL)1,553,2621,553,262066,61984,5134.08%+17,894
ARTIVA BIOTHERAPEUTICS INC(ARTV)01,736,111+1,736,111016,8400.81%+16,840
LB PHARMACEUTICALS INC(LBRX)1,438,0701,438,070034,62946,6732.25%+12,044
FAETH THERAPEUTICS INC(FTH)126,002629,467+503,4653,97215,7370.76%+11,765
VAXCYTE INC(PCVX)2,060,7192,188,636+127,917119,748127,2256.14%+7,477
ADMA BIOLOGICS INC4,756,5115,725,007+968,49642,85647,9182.31%+5,062
INVENTIVA SA(IVA)4,974,9068,163,191+3,188,28527,61130,8571.49%+3,246
CELLECTAR BIOSCIENCES INC(CLRB)0469,998+469,99801,3070.06%+1,307
VOR BIOPHARMA INC(VOR)1,925,0661,925,066034,34335,4401.71%+1,097
VERRICA PHARMACEUTICALS INC(VRCA)923,910923,91004,8875,6540.27%+767
SAB BIOTHERAPEUTICS INC(SABS)7,967,2077,967,207030,51431,0721.50%+558
ANIKA THERAPEUTICS INC1,435,1301,435,130020,80920,9961.01%+187
XILIO THERAPEUTICS INC(XLO)112,1280-112,1289430—-943
OPUS GENETICS INC(IRD)6,075,0286,077,084+2,05627,64124,9771.21%-2,665
MBX BIOSCIENCES INC(MBX)848,590200,000-648,59025,33011,0400.53%-14,290
MAZE THERAPEUTICS INC(MAZE)614,9620-614,96218,3570—-18,357
TYRA BIOSCIENCES INC(TYRA)1,276,968806,986-469,98248,90825,7751.24%-23,133
XENON PHARMACEUTICALS INC(XENE)1,393,027889,944-503,08381,00553,7172.59%-27,287
SPYRE THERAPEUTICS INC(SYRE)878,1270-878,12744,2930—-44,293
MINERALYS THERAPEUTICS INC(MLYS)2,772,6540-2,772,65475,1110—-75,111
Page 1 of 1
Caligan Partners LP — 13F Holdings — Q2 2026 | TickerTrail